Navigation Links
FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer
Date:7/23/2009

SUNNYVALE, Calif., July 23 /PRNewswire/ -- FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), today announced the appointment of Chris Barys to the position of Chief Operating Officer. Chris previously held the position of Executive VP, Sales and Marketing at FlowCardia and has over 18 years of experience in Medical Devices including the last 2 years at FlowCardia.

Prior to FlowCardia, Mr. Barys served as Vice President of Sales and Marketing for the Peripheral Vascular Systems business for Edwards Lifesciences where he had broad responsibility for this rapidly growing business segment. In his new role at FlowCardia, Mr. Barys will assume responsibility for R&D, Quality, Clinical and Regulatory functions in addition to Sales and Marketing. This move will consolidate all primary "customer touching" functions within the company under Mr. Barys.

"We are excited to have Chris take on this new role at FlowCardia as this is a critical time for the Company," said Wick Goodspeed, President and CEO of FlowCardia. "Since joining FlowCardia he has built a sales and marketing organization that has driven sales of the Company's flagship product, the CROSSER Catheter, to record success."

FlowCardia initiated commercial efforts in February of 2008 and the Company has quickly captured a market leadership position in the CTO recanalization device space. The novel CROSSER Catheter enables peripheral and coronary interventionalists to recanalize CTOs in the central lumen of the artery, allowing physicians to treat patients more definitively with a broader range of therapeutic options like atherectomy, angioplasty and stenting.

"There is a lot of momentum right now at FlowCardia with CROSSER adoption on the rise and a significant increase in sales activity," said Mr. Barys. "FlowCardia is in the midst of rapid growth and I look forward to working with the management team and accelerating operations to keep pace with the unmet clinical need of thousands of patients with CTO's."

About the CROSSER CTO Recanalization Catheter

The CROSSER CTO Recanalization Catheter is a minimally-invasive endovascular device that is delivered to a blockage within an artery using standard guidewire techniques. The doctor then activates the CROSSER Catheter which utilizes high-frequency, mechanical vibration to cross the blockage in the central lumen of the coronary or peripheral artery. Once the CROSSER Catheter passes through the occlusion and a guidewire is advanced distally, physicians can then perform standard atherectomy, balloon angioplasty and/or stent placement to optimize the longer term outcomes. For many patients, this minimally invasive approach to CTO recanalization can eliminate the need for a potentially traumatic bypass procedure or amputation.

About FlowCardia

FlowCardia, Inc. is a privately held medical device company established in 2002 to design and manufacture a portfolio of endovascular CTO recanalization products. Additional information is available on the company's web site: www.flowcardia.com.

    PR Contact Info:
    Mark Page
    Sr. Director, Marketing
    FlowCardia, Inc.
    408-617-0352 ext.301


'/>"/>
SOURCE FlowCardia, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):